Test Catalog

Test ID: NGSHM    
OncoHeme Next-Generation Sequencing for Myeloid Neoplasms

Fees Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.

  • Authorized users can sign in to Test Prices for detailed fee information.
  • Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
  • Prospective clients should contact their Regional Manager. For assistance, contact Customer Service.

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

CPT codes are provided by the performing laboratory.

81450

LOINC® Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.

Test IDTest Order NameOrder LOINC Value
NGSHMNGS for Myeloid Neoplasms (NGSHM)In Process

 

Result IDTest Result NameResult LOINC ValueApplies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
MP024Specimen Type31208-2
NGSDIndication for Test42349-1
601696NGSHM ResultNo LOINC Needed
37276Pathogenic Mutations Detected41103-3
37283Interpretation69047-9
37282Clinical Trials82786-5
37277Variants of Unknown Significance82939-0
37278Additional Notes48767-8
37279Method Summary49549-9
37420Disclaimer62364-5
37280OncoHeme Panel Gene list36908-2
37287Reviewed By:19139-5